22 news items
Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments
CADL
FGEN
ONCY
12 Jun 24
, but let this disclaimer serve as notice that all material, including this article, which is disseminated by MIQ has been approved by Oncolytics Biotech
Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments
CADL
FGEN
ONCY
12 Jun 24
will be given, but let this disclaimer serve as notice that all material, including this article, which is disseminated by MIQ has been approved by Oncolytics
Kevzara® (sarilumab) Approved by FDA for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis (pJIA)
REGN
11 Jun 24
or results may differ materially from these forward-looking statements. Words such as "anticipate," "expect," "intend," "plan," "believe," "seek," "estimate
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
REGN
31 May 24
or results may differ materially from these forward-looking statements. Words such as "anticipate," "expect," "intend," "plan," "believe," "seek
Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
REGN
31 May 24
results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements
1e1fbffs0dzazousushuwkbnuy4h09d8esrvtcndug02j605eqyb2tkxm0
REGN
31 May 24
Pharmaceuticals, Inc. ("Regeneron" or the "Company"), and actual events or results may differ materially from these forward-looking statements. Words
z1ztk
REGN
31 May 24
to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties
de8naiulo2c5zwyjc4bnwjr2bf1evexhtyrjwobvm1n5hvl8rtvi3
BHVN
REGN
29 May 24
, are not guarantees of future performance or results and involve substantial risks and uncertainties. Actual results, developments and events may differ materially
lqksq24u3vbtulrpmjgrfqmhoxgyyngav loc8gbdve
REGN
23 May 24
, Inc. ("Regeneron" or the "Company"), and actual events or results may differ materially from these forward-looking statements. Words
t9euv1tklo8 44btb7536kv0l5wvlvlqjiw
REGN
20 May 24
, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information
p9hpolbbc
REGN
20 May 24
Pharmaceuticals, Inc. ("Regeneron" or the "Company"), and actual events or results may differ materially from these forward-looking statements. Words
ksxnioh1uip0v3jk5we i2q6w9uuijhla96en2p4pzpuprea4liow8pixwv
REGN
17 May 24
, Ontario, Canada
Energy: Sustainable Materials and Design
3135qe
REGN
17 May 24
, Welland, Ontario, Canada
Energy: Sustainable Materials
48y5c19os4suyhcaxwk 6pqa5z7ew42mt6xk41crszpijjc3qwb92l
REGN
17 May 24
Systems, sponsored by HPChloe Rae and Sophie Rose Filion, Welland, Ontario, Canada Energy: Sustainable Materials
lilp7n5qjq0r89udg16z9txlek6a2exaytjr
REGN
13 May 24
or results may differ materially from these forward-looking statements. Words such as "anticipate," "expect," "intend," "plan," "believe," "seek," "estimate
y1632zwheb0jit ntzfp1hmik77xtuul8gsa6shhmq99v74geplp1c
REGN
8 May 24
and the future performance of Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company"), and actual events or results may differ materially from
1cf2dt5rixmd1an7czxv0ku1xk9mjfgp wx5sw
AAPL
AIG
AMGN
2 May 24
Fund (NYSE:XLP), up 0.6%. The Materials Select Sector
0j28v
REGN
2 May 24
"), and actual events or results may differ materially from these forward-looking statements. Words such as "anticipate," "expect," "intend
trutvlhntx9li7ded371dis0
REGN
29 Apr 24
of Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company"), and actual events or results may differ materially from these forward-looking
cnwu2ky3df288 g06giagtizn2lxrea2u18gq6qjo03z19i5w7410lmv8ch
REGN
22 Apr 24
and the future performance of Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company"), and actual events or results may differ materially from these forward